Cite
HARVARD Citation
Peyrin-Biroulet, L. et al. (n.d.). DOP73 A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis. Journal of Crohn's and colitis. pp. i116-i117. [Online].